References
Harker LA (1986) Bleeding after cardiopulmonary bypass. N Engl J Med 314:1446–1448
Bachman F, Mckenna R, Cole ER, et al. (1975) The hemostatic mechanism after open-heart surgery. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg 70:76–85
Love TR, Hendren WG, O'Keefe DD, et al. (1987) Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 43:508–512
Addonizio VP, Macarac EJ, Nicolaou KC, et al. (1979) Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Blood 53:1033–1042
Fish KJ, Sarnquist FH, Steennis CV, et al. (1986) A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operation. J Thorac Cardiovasc Surg 91:436–442
Teoh KH, Chirstakis GT, Weisel RD, et al. (1988) Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 96:332–341
Royston D, Taylor KM, Bidstrup BP, et al. (1987) Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 2:1289–1291
Bidstrup BP, Royston D, Sapsford RN, et al. (1989) Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J. Thorac Cardiovasc Surg 97:364–372
Dietrich W, Spannagl M, Jochum M, et al. (1990) Influence of high-dose aprotinin treatment of blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73:1119–1126
Salzmann E, Weinstein MJ, Weintraub RM, et al. (1986) Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 314:1402–1406
Muramatu M, Fujii S (1968) Inhibitory effects of ω-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein. J Biochem 64:807–714
Miyamoto T, Hirata H (1978) Metabolic fate of Etyl p-(6-Guanidinohexanoyloxy) Benzoate Methanesulfate (FOY) 2. Absorption, excretion and metabolism after intravenous administration in rabbit. Ouyou Yakuri 15:15–20
Matsui N, Nakagawa S, Sasaoka T, et al. (1979) Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis. Proc Eur Dial Transp Assoc 16:135–140
Taenaka N, Shimada Y, Hirata T, et al. (1982) New approach to regional anticoagulation in hemodyalysis using gabexate mesilate (FOY). Crit Care Med 10:773–775
Matsumura M, Isono M, Ishikawa M, et al. (1981) Effects of FOY on coagulofibrinolytic system during extracorporel circulation. Gendai Iryou 13:1231–1235
Tanaka K, Wei CM, Shimono T, et al. (1987) Alteration of hemostatic parameters during open heart surgery and the effects of Gabexate Mesilate (FOY) on these parameters. Jpn J Artif Organs 16:522–525
Murakawa S, Mori Y, Yamada T, et al. (1991) The effect of gabexate mesilate on coagulofibrinolytic system and platelet function during extracorporeal circulation. Jpn J Artif Organs 20:1181–1185
Arima T, Tsuji Y, Genda T, et al. (1985) The effects of gabexate mesilate on blood coagulation factors during surgery with cardiopulmonary bypass. Masui 34:1336–1342
Kucuk O, Kwaan HC, Frederickson J, et al. (1986) Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am J Hematol 23:223–229
Stibbe J, Kluft C, Brommer EJP, et al. (1984) Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 14:375–382
Harker LA, Malpass TW, Branson HE, et al. (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 56:824–834
DelRossi AJ, Cernaianu AC, Vertrees RA, et al. (1990) Plateletrich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 100:281–286
Wenger RK, Lukasiewicz H, Mikuta BS, et al. (1989) Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 97:236–239
Gluszko P, Rucinski B, Musial J, et al. (1987) Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am J Physiol 252:H615-H621
Edmunds LH (1989) Letters to the editor: Blood platelets and bypass. J Thorac Cardiovasc Surg 97:470–471
Kluft C (1991) Pathomechanisms of defective hemostasis during and after extracorporeal circulation: contact phase activation. In: Friedel N (ed) Blood use in cardiac surgery 10–15. Springer, Berlin Heidelberg New York, pp. 1:10–15
Ishihara H, Matsuda M, Tatsuta T, et al. (1980) The effect of FOY on the levels of plasminogen and high molecular weight kininogen during extracorporeal circulation with use of heart-lung machine. Arch Jpn Chir 49:187–194
Miyawaki T, Sameshima T, Miyao J, et al. (1983) Effects of FOY on lysosomes in hemorrhagic hypotension—a histological analysis. Masui 33:263–268
Author information
Authors and Affiliations
About this article
Cite this article
Kohyama, A., Goh, R., Mori, KI. et al. Effect of Gabexate mesilate on postoperative blood loss in cardiovascular surgery using cardiopulmonary bypass. J Anesth 8, 368–372 (1994). https://doi.org/10.1007/BF02514671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02514671